Sequencing Therapy for Optimal Response in Mirikizumab (STORM)-study: A tertiary referral center study on patients with therapy-refractory ulcerative colitis
Table 5
Results of the multiple logistic regression analysis of pretreatment as a predictor associated with biochemical remission.